These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16154690)

  • 41. Complement C5a: impact on the field of veterinary medicine.
    Hezmee MN; Shiels IA; Rolfe BE; Mills PC
    Vet J; 2012 Jun; 192(3):264-71. PubMed ID: 22277721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion.
    Liedtke W; Edelmann W; Chiu FC; Kucherlapati R; Raine CS
    Am J Pathol; 1998 Jan; 152(1):251-9. PubMed ID: 9422542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease.
    Luo J; Ho P; Steinman L; Wyss-Coray T
    J Neuroinflammation; 2008 Feb; 5():6. PubMed ID: 18237444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of GSM-900 microwaves on the experimental allergic encephalomyelitis (EAE) rat model of multiple sclerosis.
    Anane R; Geffard M; Taxile M; Bodet D; Billaudel B; Dulou PE; Veyret B
    Bioelectromagnetics; 2003 Apr; 24(3):211-3. PubMed ID: 12669305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuregulin1 modulation of experimental autoimmune encephalomyelitis (EAE).
    Allender E; Deol H; Schram S; Maheras KJ; Gow A; Simpson EH; Song F
    J Neuroimmunol; 2018 May; 318():56-64. PubMed ID: 29534847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complement in central nervous system inflammation.
    Barnum SR
    Immunol Res; 2002; 26(1-3):7-13. PubMed ID: 12403340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats.
    Morgan BP; Griffiths M; Khanom H; Taylor SM; Neal JW
    Clin Exp Immunol; 2004 Dec; 138(3):430-8. PubMed ID: 15544619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accumulation of protein carbonyls within cerebellar astrocytes in murine experimental autoimmune encephalomyelitis.
    Zheng J; Bizzozero OA
    J Neurosci Res; 2010 Nov; 88(15):3376-85. PubMed ID: 20857508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TNFalpha in experimental diseases of the CNS.
    Furlan R; Villa P; Senaldi G; Martino G
    Methods Mol Med; 2004; 98():171-90. PubMed ID: 15064439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis.
    Daugherty DJ; Chechneva O; Mayrhofer F; Deng W
    Sci Rep; 2016 Mar; 6():22556. PubMed ID: 26925573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Espejo C; Martínez-Cáceres EM
    Ann N Y Acad Sci; 2005 Jun; 1051():88-96. PubMed ID: 16126947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of purinergic P2X7 receptor in rat brain during the symptomatic phase of experimental autoimmune encephalomyelitis and after recovery of neurological deficits.
    Grygorowicz T; Sulejczak D; Struzynska L
    Acta Neurobiol Exp (Wars); 2011; 71(1):65-73. PubMed ID: 21499327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration.
    Osaka H; McGinty A; Höepken UE; Lu B; Gerard C; Pasinetti GM
    Neuroscience; 1999; 88(4):1073-82. PubMed ID: 10336122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis.
    Michailidou I; Jongejan A; Vreijling JP; Georgakopoulou T; de Wissel MB; Wolterman RA; Ruizendaal P; Klar-Mohamad N; Grootemaat AE; Picavet DI; Kumar V; van Kooten C; Woodruff TM; Morgan BP; van der Wel NN; Ramaglia V; Fluiter K; Baas F
    Acta Neuropathol Commun; 2018 May; 6(1):36. PubMed ID: 29724241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-human primate models of experimental autoimmune encephalomyelitis: Variations on a theme.
    't Hart BA; Bauer J; Brok HP; Amor S
    J Neuroimmunol; 2005 Nov; 168(1-2):1-12. PubMed ID: 16023737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis.
    Du S; Itoh N; Askarinam S; Hill H; Arnold AP; Voskuhl RR
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2806-11. PubMed ID: 24550311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Refined Bead-Free Method to Identify Astrocytic Exosomes in Primary Glial Cultures and Blood Plasma.
    Willis CM; Ménoret A; Jellison ER; Nicaise AM; Vella AT; Crocker SJ
    Front Neurosci; 2017; 11():335. PubMed ID: 28663721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel C5a regulators in inflammatory disease.
    Mizuno M; Cole DS
    Expert Opin Investig Drugs; 2005 Jul; 14(7):807-21. PubMed ID: 16022570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opposing roles for complement component C5a in tumor progression and the tumor microenvironment.
    Gunn L; Ding C; Liu M; Ma Y; Qi C; Cai Y; Hu X; Aggarwal D; Zhang HG; Yan J
    J Immunol; 2012 Sep; 189(6):2985-94. PubMed ID: 22914051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of C5a in acute lung injury induced by highly pathogenic viral infections.
    Wang R; Xiao H; Guo R; Li Y; Shen B
    Emerg Microbes Infect; 2015 May; 4(5):e28. PubMed ID: 26060601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.